Advertisement

European Radiology

, Volume 15, Issue 4, pp 814–822 | Cite as

Pediatric brain MRI in neurofibromatosis type I

  • Hans-J. Mentzel
  • Jörg Seidel
  • Clemens Fitzek
  • Annegret Eichhorn
  • Susanna Vogt
  • Jürgen R. Reichenbach
  • Felix Zintl
  • Werner A. Kaiser
Pediatric

Abstract

Neurofibromatosis (NF) is the most common of the phakomatoses, with a prevalence of 1 in 3–4,000. Many organ systems can be affected. In addition to multiple peripheral neurofibromas, NF I predisposed to CNS tumors including optic glioma, astrocytoma and plexiform neurofibroma. The purpose of this pictorial review is to illustrate characteristic brain MR imaging lesions in children with NF I and to give some recommendations about diagnostic imaging procedures in children suffering from NF I. Typical findings in brain MRI are hyperintense lesion on T2-weighted images, so-called unknown bright objects, which may be useful as an additional imaging criterion for NF I. Contrast administration is necessary in MR studies to maximize tumor detection and characterization, to add confidence to the diagnosis of benign probable myelin vacuolization, and to document stability of neoplasm on follow-up examinations. We recommend to perform serial MR imaging in children every 12 months. The frequency of follow-up in children with known brain tumors will vary with the tumor grade, biological activity and treatment.

Keywords

Neurofibromatosis type I Unknown bright object Optic glioma Pilocytic astrocytoma 

References

  1. 1.
    National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis. Conference statement. Arch Neurol 45:575–578Google Scholar
  2. 2.
    Guillamo JS, Creange A, Kalifa C, Grill J, Rodriguez D, Doz F, Barbarot S, Zerah M, Sanson M, Bastuji-Garin S, Wolkenstein P (2003) Prognostic factors of CNS tumors in neurofibromatosis 1 (NF 1). A retrospective study of 104 patients. Brain 126:152–160CrossRefPubMedGoogle Scholar
  3. 3.
    Mukonoweshuro W, Griffiths PD, Blaser S (1999) Neurofibromatosis type 1: the role of neuroradiology. Neuropediatrics 30:111–119PubMedGoogle Scholar
  4. 4.
    Es SV, North KN, McHugh K, Silva MD (1996) MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatr Radiol 26:478–487PubMedGoogle Scholar
  5. 5.
    Czyzyk E, Jozwiak S, Roszkowski M, Schwartz RA (2003) Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol 18:471–478PubMedGoogle Scholar
  6. 6.
    Rossi LN, Triulzi F, Parazzini C, Maninetti MM (1999) Spontaneous improvement of optic pathway lesions in children with neurofibromatosis type 1. Neuropediatrics 30:205–209PubMedGoogle Scholar
  7. 7.
    Singhal S, Birch JM, Kerr B, Lashford L, Evans DG (2002) Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 87:65–70CrossRefPubMedGoogle Scholar
  8. 8.
    Riffaud L, Vinchon M, Ragragui O, Delestret I, Ruchoux MM, Dhellemmes P (2002) Hemispheric cerebral gliomas in children with NF 1: arguments for a long-term follow-up. Childs Nerv Syst 18:43–47CrossRefPubMedGoogle Scholar
  9. 9.
    Ilgren EB, Kinnnier-Wilson LM, Stiller CA (1985) Gliomas in neurofibromatosis: a series of 89 cases with evidence for increased malignancy in associated cerebellar astrocytomas. Pathol Ann 20:331–358Google Scholar
  10. 10.
    Pollack IF, Shultz B, Mulvihill JJ (1996) The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 46:1652–1660PubMedGoogle Scholar
  11. 11.
    Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF 1 optic pathway glioma task force. Ann Neurol 41:143–149PubMedGoogle Scholar
  12. 12.
    Elster AD (1992) Radiologic screening in the neurocutaneous syndromes: strategies and controversies. Am J Neuroradiol 13:1078–1082PubMedGoogle Scholar
  13. 13.
    Griffiths PD, Blaser S, Mukonoweshuro W, Armstrong D, Milo-Manson G, Cheung S (1999) Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 104(4):e49PubMedGoogle Scholar
  14. 14.
    Vinchon M, Soto-Ares G, Ruchoux MM, Dhellemmes P (2000) Cerebellar gliomas in children with NF 1: pathology and surgery. Childs Nerv Syst 16:417–420PubMedGoogle Scholar
  15. 15.
    Jacquemin C, Bosley TM, Svedberg H (2003) Orbit deformities in craniofacial neurofibromatosis type 1. Am J Neuroradiol 24:1678–1682PubMedGoogle Scholar
  16. 16.
    Meersschaut VA, Kros JM, Catsman-Berrevoets CE, Lequin MH (2003) Congenital bilateral plexiform neurofibromas of the cavernous sinuses. Pediatr Radiol 33:272–274PubMedGoogle Scholar
  17. 17.
    Raininko R, Thelin L, Eeg-Olofsson O (2001) Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1. Neuropediatrics 32:225–230CrossRefPubMedGoogle Scholar
  18. 18.
    DeBella K, Poskitt K, Szudek J, Friedman JM (2000) Use of “unidentified bright objects” on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 54:1646–1650PubMedGoogle Scholar
  19. 19.
    Wieshmann UC, Clark CA, Symms MR (1999) Reduced anistotropy of water diffusion in structural cerebral abnormalities demonstrated with diffusion tensor imaging. Magn Res Imaging 17:1269–1274CrossRefGoogle Scholar
  20. 20.
    Sener RN, Dzelzite S, Migals A, Raits U, Veinbergs AA (2003) Prominent myelin vacuolization in neurofibromatosis type 2. J Clin Imaging 27:11–13CrossRefGoogle Scholar
  21. 21.
    Mori H, Abe O, Okubo T, Hayashi N, Yoshikawa T, Kunimatsu A, Yamada H, Aoki S, Ohtomo K (2001) Diffusion property in a hamartomatous lesion of neurofibromatosis type 1. J Comput Assist Tomogr 25:537–539CrossRefPubMedGoogle Scholar
  22. 22.
    Eastwood JD, Fiorella DJ, MacFall JF, Delong DM, Provenzale JM, Greenwood RS (2001) Increased brain apparent diffusion coefficient in children with neurofibromatosis type 1. Radiology 219:354–358PubMedGoogle Scholar
  23. 23.
    Sheikh SF, Kubal WS, Anderson AW, Mutalik P (2003) Longitudinal evaluation of apparent diffusion coefficient in children with neurofibromatosis type 1. J Comput Assist Tomogr 27:681–686CrossRefPubMedGoogle Scholar
  24. 24.
    Sener RN (2002) Diffusion MRI in neurofibromatosis type a: ADC evaluations of the optic pathways, and a comparison with normal individuals. Comput Med Imaging Graph 26:59–64CrossRefPubMedGoogle Scholar
  25. 25.
    Sevick RJ, Barkovich AJ, Edwards MSB, Koch T, Berg B, Lempert T (1992) Evolution of white matter lesions in neurofibromatosis type 1: MR findings. Am J Roentgenol 159:171–175Google Scholar
  26. 26.
    Aoki S, Barkovich AJ, Nishimura K, Kjos BO, Machida T, Cogen P, Edwards M, Norman D (1989) Neurofibromatosis types 1 & 2: cranial MR findings. Radiology 172:527–534PubMedGoogle Scholar
  27. 27.
    Terada H, Barkovich AJ, Edwards MSB, Cercillo SF (1996) Evolution of high-intensity basal ganglia lesions on T1 weighted MR in neurofibromatosis type 1. Am J Neuroradiol 17:755–760PubMedGoogle Scholar
  28. 28.
    Legius E, Descheemaeker MJ, Steyaert J, Spaepen A, Vlietinck R, Casaer P, Demaerel P, Fryns JP (1995) Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. J Neurol Neurosurg Psychiatry 59:635–640PubMedGoogle Scholar
  29. 29.
    Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM (1996) Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46:1660–1668PubMedGoogle Scholar
  30. 30.
    Hyman SL, Gill DS, Shores EA, Steinberg A, Joy P, Gibikote SV, North KN (2003) Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF 1. Neurology 60:1139–1145PubMedGoogle Scholar
  31. 31.
    Pinson S, Creange A, Barbarot S, Stalder JF, Chaix Y, Rodriguez D, Sanson M, Bernheim A, d’Incan M, Doz F, Stoll C, Combemale P, Kalifa C, Zeller J, Teillac-Hamel D, Lyonnet S, Zerah M, Lacour JP, Guillot B, Wolkenstein P (2002) Neurofibromatosis 1: recommendations for management. Arch Pediatr 9:49–60CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Hans-J. Mentzel
    • 1
  • Jörg Seidel
    • 2
  • Clemens Fitzek
    • 1
  • Annegret Eichhorn
    • 2
  • Susanna Vogt
    • 1
  • Jürgen R. Reichenbach
    • 1
  • Felix Zintl
    • 2
  • Werner A. Kaiser
    • 1
  1. 1.Department of Pediatric Radiology, Institute of Diagnostic and Interventional RadiologyFriedrich-Schiller-University JenaJenaGermany
  2. 2.Department of PediatricsFriedrich-Schiller-University JenaJenaGermany

Personalised recommendations